{"id":1836,"date":"2026-04-17T12:00:32","date_gmt":"2026-04-17T12:00:32","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/04\/17\/enrollment-complete-in-phase-3-trial-of-at-home-briumvi-injection-for-ms\/"},"modified":"2026-04-17T12:00:32","modified_gmt":"2026-04-17T12:00:32","slug":"enrollment-complete-in-phase-3-trial-of-at-home-briumvi-injection-for-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/04\/17\/enrollment-complete-in-phase-3-trial-of-at-home-briumvi-injection-for-ms\/","title":{"rendered":"Enrollment complete in Phase 3 trial of at-home Briumvi injection for MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/04\/17\/enrollment-complete-trial-home-briumvi-injection-ms\/\" title=\"Enrollment complete in Phase 3 trial of at-home Briumvi injection for MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"756\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/04\/iStock-2178736730-800x756.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"Illustration of two women reviewing a medical checklist and treatment plan on large documents, representing patient care and monitoring.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"161356\" \/><\/a><\/p>\n<p>Patient enrollment is complete in a Phase 3 trial testing a new formulation of Briumvi (ublituximab-xiiy), TG Therapeutics&#8216;\u00a0multiple sclerosis (MS) medication for relapsing forms of the disease, that could be injected at home. The new formulation is designed to be given under the skin, or subcutaneously, every two or three months, which could offer a [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/04\/17\/enrollment-complete-trial-home-briumvi-injection-ms\/\">Enrollment complete in Phase 3 trial of at-home Briumvi injection for MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/04\/17\/enrollment-complete-trial-home-briumvi-injection-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Patient enrollment is complete in a Phase 3 trial testing a new formulation of Briumvi (ublituximab-xiiy), TG Therapeutics&#8216;\u00a0multiple sclerosis (MS) medication for relapsing forms of the disease, that could be injected at home. The new formulation is designed to be given under the skin, or subcutaneously, every two or three months, which could offer a&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1837,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1836","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1836"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1836\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1837"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}